Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genmab Appoints CDO | Contract Pharma
Promotions & Moves

Genmab Appoints CDO

Klimovsky to lead Genmab’s product development strategy

Judith Klimovsky, MD, has been appointed executive vice president and chief development officer (CDO), Genmab. Dr. Klimovsky will lead the company’s global product development activities and will join the executive team.

Dr. Klimovsky will be responsible for Genmab’s product development strategy in line with the company’s corporate strategy. Dr. Klimovsky brings extensive drug development experience, most recently serving as senior vice president and global head, Oncology Clinical Development, at Novartis. She is a hematologist by training with experience in various roles at BMS, Merck and Novartis, as well as in hematology clinical practice.

“We are very pleased to welcome Judith to Genmab. She has a strong  track record and skills in cancer drug development which will further strengthen the company as we build a winning team to continue our success in the future on the road to becoming a sustainably profitable biotech company,” said Jan van de Winkel, Ph.D., chief executive officer of Genmab. “With Judith heading our product development efforts we will be able to bring forward truly differentiated products that have the potential to transform the treatment of cancer and provide great benefits to patients and their families in the future.”

Dr. Klimovsky will be based at the company’s Princeton, NJ location, with regular travel to the company’s locations in Copenhagen, Denmark and Utrecht, The Netherlands.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters